In vitro allergy diagnosis: Guideline of the DGAI in coordination with the DDG;In-vitro-Allergiediagnostik: Leitlinie der DGAI in abstimmung mit der DDG

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 1, 2006, Pages 72-85

  Renz, Harald ^a   Becker, Wolf Meinhard ^b   Bufe, Albrecht ^b   Kleine Tebbe, Jörg ^b   Raulf Heimsoth, Monika ^b   Saloga, Joachim ^b   Werfel, Thomas ^b   Worm, Margitta ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4;

ALLERGY; ALLERGY TEST; ATOPY; BASOPHIL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EOSINOPHIL; GRANULOCYTE; HUMAN; IMMUNE FUNCTION TEST; IMMUNOASSAY; INFECTION; REVIEW; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; BASOPHIL DEGRANULATION TEST; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; GERMANY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; LYMPHOCYTE ACTIVATION; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL;

EID: 33645237336     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.04350.x     Document Type: Review

References (75)

1. AAAAI, B. o. D. Position statement. Measurement of specific and nonspecific IgG4 levels as diagnostic and prognostic tests for clinical allergy. J Allergy Clin Immunol 1995; 95: 652-4.
2. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995; 95: 913-8.
3. Baldwin CI, Todd A, Bourke S, Allen A, Calvert JE. Pigeon fanciers' lung: effects of smoking on serum and salivary antibody responses to pigeon antigens. Clin Exp Immunol 1998; 113: 166-72.
4. Baur X, Richter G, Pethran A, Czuppon AB, Schwaiblmair M. Increased prevalence of IgG-induced sensitization and hypersensitivity pneumonitis (humidifier lung) in nonsmokers exposed to aerosols of a contaminated air conditioner. Respiration 1992; 59: 211-4.
5. Berg PA, Daniel PT, Brattig N. Immunologie und Nachweis medikamentöser Allergien. In: Fuchs E, Schulz KH, Hrsg.Manuale Allergologicum IV. Deisenhofen:Dustri Verlag Dr. Karl Feistle, 1996: 1-13.
6. Bergmann K-C, Costabel U, Knape H, Kroidl R, Müller-Wening D, Repp H, Rust M, Schwarz H, Sennekamp J. Empfehlungen zur Diagnosestellung einer exogen-allergischen Alveolitis. Allergologie 1990; 3: 111-2.
7. Bergmann RL, Edenharter G, Bergmann KE, Guggenmoos-Holzmann I, Forster J, Bauer CP, Wahn V, Zepp F, Wahn U. Predictability of early atopy by cord blood-IgE and parental history. Clin Exp Allergy 1997; 27: 752-60.
8. Beyer K, Niggemann B, Schulze S, Wahn U. Serum tryptase and urinary 1-methylhistamine as parameters for monitoring oral food challenges in children. Int Arch Allergy Immunol 1994; 104: 348-51.
9. Biedermann T, Rueff F, Sander CA, Przybilla B. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Br J Dermatol 1999; 141: 1110-2.
10. Bjorksten B. Immunological outcome measures. Eur Respir J Suppl 1996; 21: 22s-7s.
11. Boccagni P, Favari F, Zanoni G, Pezzini A, Tridente G. Comparison of four in vitro assays for specific IgE detection. Int J Clin Lab Res 1994; 24: 102-5.
12. Bodycote J, Wolff S. Metabolic breakdown of [3H]thymidine and the inability to measure human lymphocyte proliferation by incorporation of radioactivity. Proc Natl Acad Sci U S A 1986; 83: 4749-53.
13. Boeker M, Werfel T. In vitro Untersuchungen von Antigen- und Allergen-spezifisch aktivierten mononukleären Zellen. Allergologie 1994; 17: 374-9.
14. Boluda L, Fernandez-Caldas E, Berrens L. The role of IgG in type-I allergy: an unsolved problem. J Investig Allergol Clin Immunol 1997; 7: 205-10.
15. Brehler R, Becker D, Merk H. MELISA - In-vitro Test zum Nachweis einer Kontaktallergie? Eine Stellungnahme der Deutschen Kontaktallergie-Gruppe. Hautarzt 1998;49: 418-9.
16. Brockow K, Vieluf D, Puschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999; 104: 237-8.
17. Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99: 314-22.
18. Cahen YD, Maly FE, Wuthrich B. Cellular Antigen Stimulation Test (CAST) - Verwendbarkeit in der Diagnostik von Insektenallergien. Schweiz Med Wochenschr 1997; 127: 5-11.
19. Cederbrant K, Hultman P, Marcusson JA, Tibbling L. In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int Arch Allergy Immunol 1997; 112: 212-7.
20. Crameri R. Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998; 115: 99-114.
21. Crobach MJ, Kaptein AA, Kramps JA, Hermans J, Ridderikhoff J, Mulder JD. The Phadiatop test compared with RAST, with the CAP system; proposal for a third Phadiatop outcome:"inconclusive". Allergy 1994; 49: 170-6.
22. Czech W, Krutmann J, Schopf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992; 126: 351-5.
23. De Week AL. Zellulärer Allergen-Stimulierungs-Test (CAST). Allergologie 1997; 20: 487-502.
24. Eich-Wanger C, Müller UR. Bee sting allergy in beekeepers. Clin Exp Allergy 1998; 28: 1292-8.
25. Eigenmann PA, Tropia L, Hauser C. The mucosal adhesion receptor alpha4beta7 integrin is selectively increased in lymphocytes stimulated with beta-lactoglobulin in children allergic to cow's milk. J Allergy Clin Immunol 1999; 103: 931-6.
26. Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000; 7: 32-9.
27. Gehlhar K, Schlaak M, Becker W, Bufe A. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy 1999; 29: 497-506.
28. Hammar E, Berglund A, Hedin A, Norrman A, Rustas K, Ytterstrom U, Akerblom E. An immunoassay for histamine based on monoclonal antibodies. J Immunol Methods 1990; 128: 51-8.
29. Hertl M, Merk HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995; 105: 95S-8S.
30. Holford-Strevens V, Warren P, Wong C, Manfreda J. Serum total immunoglobulin E levels in Canadian adults. J Allergy Clin Immunol 1984; 73: 516-22.
31. Hvatum M, Scott H, Brandtzaeg P. Pitfalls in determining IgG and IgG subclass antibodies to food antigens. J Immunol Methods 1992; 148: 77-85.
32. Karplus TE, Ulevitch RJ, Wilson CB. A new method for reduction of endotoxin contamination from protein solutions. J Immunol Methods 1987; 105: 211-20.
33. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM. Multiple defects in Fc epsilon RI signaling in Syk-deficient nonreleaser basophils and IL-3-induced recovery of Syk expression and secretion. J Immunol 2000; 165: 5913-20.
34. Kleine-Tebbe J. Basophil histamine release by freshly prepared food extracts. Allergy Proc 1993; 14: 255-8.
35. Knol EF, Mul FP, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991; 88: 328-38.
36. Kondo N, Agata H, Fukutomi O, Motoyoshi F, Orii T. Lymphocyte responses to food antigens in patients with atopic dermatitis who are sensitive to foods. J Allergy Clin Immunol 1990; 86: 253-60.
37. Koponen M, Pichler WJ, de Weck AL. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 1986; 78: 645-52.
38. Kulig M, Tacke U, Forster J, Edenharter G, Bergmann R, Lau S, Wahn V, Zepp F, Wahn U. Serum IgE levels during the first 6 years of life. J Pediatr 1999; 134: 453-8.
39. Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001; 56: 688-92.
40. MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993; 91: 605-15.
41. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. J Immunol 1986; 136: 2231-9.
42. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462-72.
43. May A, Weber A, Gall H, Kaufmann R, Zöllner TM. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 1999; 29: 1402-11.
44. Mensing H. Zur Differentialdiagnose der Dermatitis atopica. Allergologie 1994; 17: 477-80.
45. Merk HF. In-vitro-Diagnostik bei Arzneimittel-Allergien. Allergologie 1988; 11: 57-9.
46. Merk HF. Arzneimittelallergie: Einfluss des Fremdstoff-Metabolismus. Allergologie 1989; 12: 171-3.
47. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigenpresenting cell function? Immunol Today 1993; 14:161-4.
48. Moneret-Vautrin DA, Sainte-Laudy J, Kanny G, Fremont S. Human basophil activation measured by CD63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999; 82: 33-40.
49. Mundt C, Becker WM, Schlaak M. Farmer's lung: patients' IgG2 antibodies specifically recognize Saccharopolyspora rectivirgula proteins and carbohydrate structures. J Allergy Clin Immunol 1996; 98: 441-50.
50. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175-81.
51. Pichler WJ. Der Lymphozytentransformationstest in der Diagnostik von unerwünschten Arzneimittelreaktionen. In:Merk HF, Hrsg. Allergische und pseudoallergische Arzneimittelreaktionen. 1993: 119-30.
52. Rasanen L, Sainio H, Lehto M, Reunala T. Lymphocyte proliferation test as a diagnostic aid in chromium contact sensitivity. Contact Dermatitis 1991; 25: 25-9.
53. Rasanen L, Tuomi ML. Diagnostic value of the lymphocyte proliferation test in nickel contact allergy and provocation in occupational coin dermatitis. Contact Dermatitis 1991; 27: 250-4.
54. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999; 104: 466-72.
55. Reese G, Becker WM, Schlaak M. Farmerlunge: IgGSubklassenreaktivitä ten gegen thermophile Aktinomyzeten. Immun Infekt 1989; 17: 59-60.
56. Rothenberg ME. Eosinophilia. N Engl J Med 1998; 338:1592-600.
57. Roujeau JC, Albengres E, Moritz S, Piacentino A, Cuny M, Revuz J, Touraine R. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int Arch Allergy Appl Immunol 1985; 78: 22-4.
58. Sainte-Laudy J, Sabbah A, Drouet M, Lauret MG, Loiry M. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin tests, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000; 30: 1166-71.
59. Saporta M, Kamei S, Persi L, Bousquet J, Arnoux B. Basophil activation during pollen season in patients monosensitized to grass pollens. Allergy 2001; 56:442-5.
60. Schreiber J, Zissel G, Greinert U, Galle J, Schulz KH, Schlaak M, Muller-Quernheim J. Diagnostik der chronischen Berylliose. Pneumologie 1999; 53: 193-8.
61. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83: 1551-5.
62. Sitzmann F. Normalwerte. München: Hans Marseille Verlag, 1986.
63. Stejskal VD, Olin RG, Forsbeck M. The lymphocyte transformation test for diagnosis of drug-induced occupational allergy. J Allergy Clin Immunol 1986; 77: 411-26.
64. Sutton BJ, Gould HJ. The human IgE network. Nature 1993; 366: 421-8.
65. Tiikkainen U, Klockars M. Clinical significance of IgG subclass antibodies to wheat flour antigens in bakers. Allergy 1990; 45: 497-504.
66. Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999; 29:1172-86.
67. Wahn V. Differentialdiagnose kindlicher Immundefekte. Prädiat Prax 1998; 55: 79-100.
68. Wedi B, Elsner J, Kapp A. In vitro diagnostic of pseudoallergic reactions - new aspects. ACI Int 1996; 8: 113-5.
69. Wells AD, Gudmundsdottir H, Turka LA. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J Clin Invest 1997; 100: 3173-83.
70. Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A. Detection of a kappa-casein-specific lymphocyte response in milk-responsive atopic dermatitis. Clin Exp Allergy 1996; 26: 1380-6.
71. Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A, Neumann C. Milk-responsive atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients. J Allergy Clin Immunol 1997; 99: 124-33.
72. Werfel T, Boeker M, Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy 1997; 52: 465-9.
73. Werfel T, Hentschel M, Kapp A, Renz H. Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol 1997; 158: 2500-5.
74. Winther L, Moseholm L, Reimert CM, Stahl Skov P, Kaergaard Poulsen L. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Allergy 1999; 54: 436-45.
75. Wistokat-Wülfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999; 29: 513-21.